Ma L - Search Results

1

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.

Shan J, Shen J, Liu L, Xia F, Xu C, Duan G, Xu Y, Ma Q, Yang Z, Zhang Q, Ma L, Liu J, Xu S, Yan X, Bie P, Cui Y, Bian XW, Qian C. Shan J, et al. Among authors: ma l, ma q. Hepatology. 2012 Sep;56(3):1004-14. doi: 10.1002/hep.25745. Epub 2012 Jul 12. Hepatology. 2012. PMID: 22473773

2

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells.

Ma L, Liu J, Shen J, Liu L, Wu J, Li W, Luo J, Chen Q, Qian C. Ma L, et al. Cancer Biol Ther. 2010 Apr 1;9(7):554-61. doi: 10.4161/cbt.9.7.11267. Epub 2010 Apr 1. Cancer Biol Ther. 2010. PMID: 20150764 Free article.

3

Potent antitumor activity in experimental hepatocellular carcinoma by adenovirus-mediated coexpression of TRAIL and shRNA against COX-2.

Chen Q, Lou W, Shen J, Ma L, Yang Z, Liu L, Luo J, Qian C. Chen Q, et al. Among authors: ma l. Clin Cancer Res. 2010 Jul 15;16(14):3696-705. doi: 10.1158/1078-0432.CCR-09-3097. Epub 2010 Jun 1. Clin Cancer Res. 2010. PMID: 20515870

4

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

Xu Y, Xia F, Ma L, Shan J, Shen J, Yang Z, Liu J, Cui Y, Bian X, Bie P, Qian C. Xu Y, et al. Among authors: ma l. Cancer Lett. 2011 Nov 28;310(2):160-9. doi: 10.1016/j.canlet.2011.06.027. Epub 2011 Jul 2. Cancer Lett. 2011. PMID: 21802841

5

Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44⁺ gastric cancer cells via attenuating Wnt signaling.

Wang B, Liu J, Ma LN, Xiao HL, Wang YZ, Li Y, Wang Z, Fan L, Lan C, Yang M, Hu L, Wei Y, Bian XW, Chen D, Wang J. Wang B, et al. Among authors: ma ln. J Gastroenterol. 2013 Jul;48(7):798-808. doi: 10.1007/s00535-012-0711-z. Epub 2012 Nov 28. J Gastroenterol. 2013. PMID: 23188090

6

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, Cui Y, Bian XW, Qian C. Lou W, et al. Among authors: ma l. J Mol Med (Berl). 2013 Jun;91(6):715-25. doi: 10.1007/s00109-012-0985-x. Epub 2013 Jan 6. J Mol Med (Berl). 2013. PMID: 23292172

7

Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.

Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y, Xia F, Shan J, Shen J, Yang Z, Bie P, Cui Y, Bian XW, Prieto J, Avila MA, Qian C. Ma L, et al. Cancer Res. 2014 Mar 1;74(5):1452-62. doi: 10.1158/0008-5472.CAN-13-2171. Epub 2014 Jan 3. Cancer Res. 2014. PMID: 24390737

8

Oleanolic acid inhibits proliferation and invasiveness of Kras-transformed cells via autophagy.

Liu J, Zheng L, Ma L, Wang B, Zhao Y, Wu N, Liu G, Lin X. Liu J, et al. Among authors: ma l. J Nutr Biochem. 2014 Nov;25(11):1154-1160. doi: 10.1016/j.jnutbio.2014.06.006. Epub 2014 Jul 31. J Nutr Biochem. 2014. PMID: 25172632

9

Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.

Liu J, Ma L, Wu N, Liu G, Zheng L, Lin X. Liu J, et al. Among authors: ma l. Mar Drugs. 2014 Sep 25;12(9):5072-88. doi: 10.3390/md12095072. Mar Drugs. 2014. PMID: 25257790 Free PMC article.

10

MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.

Xu Y, Huang J, Ma L, Shan J, Shen J, Yang Z, Liu L, Luo Y, Yao C, Qian C. Xu Y, et al. Among authors: ma l. Cancer Lett. 2016 Feb 28;371(2):171-81. doi: 10.1016/j.canlet.2015.11.034. Epub 2015 Dec 3. Cancer Lett. 2016. PMID: 26655273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,198 results

Search Page

Filters